Catherine M Spier Selected Research

Catherine M Spier Research Topics

4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2015 - 10/2006
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2015 - 06/2004
3	Lymphoma (Lymphomas) 01/2013 - 06/2004
2	COVID-19 11/2020 - 08/2020
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2008 - 06/2004
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2013
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2013
1	Leukemia 06/2004
1	Neoplasms (Cancer) 06/2004

4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 10/2006
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 06/2004
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 05/2008
3	Prednisone (Sone)FDA LinkGeneric 01/2018 - 05/2008
3	Vincristine (Oncovin)FDA LinkGeneric 01/2018 - 05/2008
2	Rituximab (Mabthera)FDA Link 01/2018 - 05/2008
1	Neutralizing AntibodiesIBA 11/2020
1	AntibodiesIBA 11/2020
1	IodineIBA 01/2018
1	ibritumomab tiuxetan (Zevalin)FDA Link 01/2015
1	4- imino- 1,3- diazabicyclo(3.1.0)hexan- 2- oneIBA 08/2014
1	Anaplastic Lymphoma KinaseIBA 01/2013
1	Methylprednisolone FDA LinkGeneric 01/2013
1	Cisplatin (Platino)FDA LinkGeneric 01/2013
1	Gemcitabine FDA Link 01/2013
1	Etoposide (VP 16)FDA LinkGeneric 01/2013
1	Biological ProductsIBA 05/2008
1	DNA (Deoxyribonucleic Acid)IBA 06/2004